Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411912 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Arseny D Moralev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Ave., 8, 630090 Novosibirsk, R…. Hauptthemen laut MEDLINE: Doxorubicin, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian state-funded project for ICBFM SB RAS.
Abstract (Originalsprache)
Multidrug resistance (MDR) remains a significant obstacle to effective cancer chemotherapy, primarily due to overexpression of P-glycoprotein (P-gp), which reduces intracellular accumulation of cytotoxic drugs. This study evaluated the pharmacological potential of the glycyrrhetinic acid derivative soloxolone N-3-(dimethylamino)propylamide (Sol-DMAP) as a biocompatible P-gp inhibitor with hepatoprotective properties. Using a murine model of P-gp-overexpressing RLS40 lymphosarcoma, we demonstrated that Sol-DMAP significantly enhanced the antitumor efficacy of doxorubicin (DOX) by increasing its intratumoral concentration 4.7-fold without enhancing systemic toxicity. Independently, Sol-DMAP exhibited direct antitumor activity, reducing tumor growth in vivo and inducing apoptosis and G1-phase arrest in RLS40 cells in vitro. In addition, Sol-DMAP mitigated DOX-induced hepatic injury by reducing necrotic and dystrophic changes in liver tissue and restoring heme oxygenase 1 (Hmox1) expression. Further studies in HepG2 cells confirmed that Sol-DMAP activated the NRF2-dependent antioxidant response, upregulating HMOX1, GCLC, GCLM, and NQO1 genes. Molecular docking revealed that Sol-DMAP can disrupt the KEAP1-NRF2 interaction, likely leading to NRF2 activation. Collectively, these findings demonstrate that Sol-DMAP effectively reverses P-gp-mediated MDR while protecting the liver from oxidative stress, highlighting its potential as a multifunctional scaffold for the development of safer and more effective chemotherapeutic adjuvants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Ave., 8, 630090 Novosibirsk, Russia.
- Faculty of Natural Sciences, Novosibirsk State University, Pirogov St. 2, 630090 Novosibirsk, Russia.
- N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrent'ev Ave., 9, 630090 Novosibirsk, Russia.
ORCID-Profile: Arseny D Moralev, Aleksandra V Sen'kova, Artem D Rogachev, Marina A Zenkova, Andrey V Markov
Förderung
- Russian Science Foundation
- Russian state-funded project for ICBFM SB RAS
Zitieren
APA
Moralev, A. D., Sen'kova, A. V., Firsova, A. A., Solomina, D. E., Rogachev, A. D., Salomatina, O. V., Salakhutdinov, N. F., Zenkova, M. A., & Markov, A. V. (2025). Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411912
Vancouver
Moralev AD, Sen'kova AV, Firsova AA, Solomina DE, Rogachev AD, Salomatina OV, et al. Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411912
BibTeX
@article{Moralev2025,
author = {Moralev, Arseny D and Sen'kova, Aleksandra V and Firsova, Alina A and Solomina, Daria E and Rogachev, Artem D and Salomatina, Oksana V and Salakhutdinov, Nariman F and Zenkova, Marina A and Markov, Andrey V},
title = {Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411912}
}
EUVIMED